{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,4]],"date-time":"2026-09-04T09:38:06Z","timestamp":1788514686925,"version":"build-2803163510"},"reference-count":71,"publisher":"Oxford University Press (OUP)","issue":"1","license":[{"start":{"date-parts":[[2025,12,30]],"date-time":"2025-12-30T00:00:00Z","timestamp":1767052800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":[],"published-print":{"date-parts":[[2026,2,4]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:p>In 1806, French physician Baron Jean-Louis Alibert saw a man with a desquamating rash and skin tumours. Alibert considered this to be a variant of yaws. In 1829 Alibert named the condition mycosis fungoides (MF), meaning \u2018mushroom-like fungal disease\u2019. Over 100 years later, French dermatologist Albert S\u00e9zary published papers from 1938 to 1949 detailing a mysterious disease containing \u2018cellules monstrueuses\u2019, describing cutaneous \u2018monster cells\u2019. In 1961, these clinical findings were collated together into \u2018S\u00e9zary syndrome\u2019. In the 1870s English dermatologist William Tilbury Fox published a dermatology atlas detailing cases similar to what we know now as MF, with the name \u2018fibroma fungoides\u2019. The atlas described MF as a type of fungus, before giving a description of yaws and painting a clinical picture that differed from that of a lymphoma. Over the twentieth century, our understandings of the origins of MF were changing and by 1975 the classification system and term we now recognize as cutaneous T-cell lymphoma (CTCL) was developed. Neoplastic cells have been thought to arise from chronic activation of T cells via antigen-presenting cells due to inappropriate cytokines and C-C chemokine receptors. In 2018, the World Health Organization and European Organisation for Research and Treatment of Cancer officially recognized four variants of MF. These are the classic Alibert\u2013Bazin variant and its three variants: folliculotropic MF, pagetoid reticulosis and granulomatous slack skin. Developments in immunohistochemistry for the T-cell receptor gene in the 1990s improved the diagnosis of CTCL; however, diagnosis is still challenging. Advanced MF therapies have evolved from cytotoxic chemotherapy to novel monoclonal antibodies such as mogamulizumab, targeting proteins on T-cell lymphoma cells.<\/jats:p>","DOI":"10.1093\/skinhd\/vzaf099","type":"journal-article","created":{"date-parts":[[2025,11,6]],"date-time":"2025-11-06T13:15:39Z","timestamp":1762434939000},"page":"30-34","source":"Crossref","is-referenced-by-count":1,"title":["A historical review of mycosis fungoides: from Alibert to mogamulizumab"],"prefix":"10.1093","volume":"6","author":[{"ORCID":"https:\/\/orcid.org\/0009-0000-4027-1751","authenticated-orcid":false,"given":"Nicholas A","family":"Johnson","sequence":"first","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0009-0009-3712-7738","authenticated-orcid":false,"given":"Opeoluwa","family":"Fariyike","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0003-4770-9335","authenticated-orcid":false,"given":"Khaylen","family":"Mistry","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich ,","place":["UK"]},{"name":"Department of Dermatology, Norfolk and Norwich University Hospital , Norwich ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zoe","family":"Venables","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich ,","place":["UK"]},{"name":"Department of Dermatology, Norfolk and Norwich University Hospital , Norwich ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nick J","family":"Levell","sequence":"additional","affiliation":[{"name":"Norwich Medical School, University of East Anglia , Norwich ,","place":["UK"]},{"name":"Department of Dermatology, Norfolk and Norwich University Hospital , Norwich ,","place":["UK"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"286","published-online":{"date-parts":[[2025,12,30]]},"reference":[{"key":"2026020400220145200_vzaf099-B1","first-page":"200","volume-title":"Descriptions de la maladie de la peau observ\u00e9e \u00e0 l'H\u00f4pital Saint-Louis","author":"Alibert","year":"1837"},{"key":"2026020400220145200_vzaf099-B2","volume-title":"Medical Microbiology","author":"Radolf","year":"1996","edition":"4th edn"},{"key":"2026020400220145200_vzaf099-B3","volume-title":"Dermatology in France","author":"Wallach","year":"2002"},{"key":"2026020400220145200_vzaf099-B4","first-page":"143","volume-title":"The British Journal of Dermatology","author":"Funk","year":"1888-9"},{"key":"2026020400220145200_vzaf099-B5","volume-title":"On Diseases of the Skin","author":"Wilson","year":"1852"},{"key":"2026020400220145200_vzaf099-B6","doi-asserted-by":"crossref","first-page":"21","DOI":"10.1186\/s41182-024-00586-4","article-title":"Why avoid naming diseases after animals? The case of \u201cMolluscum contagiosum\u201d","volume":"52","author":"Machado","year":"2024","journal-title":"Trop Med Health"},{"key":"2026020400220145200_vzaf099-B7","doi-asserted-by":"crossref","first-page":"228","DOI":"10.1016\/0002-9343(63)90056-1","article-title":"Mycosis fungoides. Natural history and aspects of its relationship to other malignant lymphomas","volume":"34","author":"Block","year":"1963","journal-title":"Am J Med"},{"key":"2026020400220145200_vzaf099-B8","first-page":"190","article-title":"Discussion on mycosis fungoides","volume":"7","author":"Sequeira","year":"1914","journal-title":"Proc R Soc Med"},{"key":"2026020400220145200_vzaf099-B9","volume-title":"Atlas of Skin Diseases","author":"Fox","year":"1877"},{"key":"2026020400220145200_vzaf099-B10","doi-asserted-by":"crossref","first-page":"747","DOI":"10.4103\/ijdvl.IJDVL_1100_19","article-title":"Pautrier\u2019s microabscess: an eponym by mistake","volume":"86","author":"Bhat","year":"2020","journal-title":"Indian J Dermatol Venereol Leprol"},{"key":"2026020400220145200_vzaf099-B11","doi-asserted-by":"crossref","first-page":"848","DOI":"10.1097\/DAD.0000000000002054","article-title":"Pautrier microabscess: a topic of great controversy","volume":"43","author":"Giessinger","year":"2021","journal-title":"Am J Dermatopathol"},{"key":"2026020400220145200_vzaf099-B12","doi-asserted-by":"crossref","first-page":"796","DOI":"10.1067\/mjd.2003.248","article-title":"The myth of Pautrier\u2019s microabscesses","volume":"48","author":"Cribier","year":"2003","journal-title":"J Am Acad Dermatol"},{"key":"2026020400220145200_vzaf099-B13","doi-asserted-by":"crossref","first-page":"357","DOI":"10.1097\/00000372-200608000-00014","article-title":"The man behind the eponym dermatology in historical perspective: Albert S\u00e9zary and the S\u00e9zary syndrome","volume":"28","author":"Steffen","year":"2006","journal-title":"Am J Dermatopathol"},{"key":"2026020400220145200_vzaf099-B14","doi-asserted-by":"crossref","first-page":"465","DOI":"10.1001\/jama.1961.03040330001001","article-title":"S\u00e9zary syndrome \u2013 a malignant reticulemic erythroderma","volume":"177","author":"Taswell","year":"1961","journal-title":"JAMA"},{"key":"2026020400220145200_vzaf099-B15","doi-asserted-by":"crossref","first-page":"534","DOI":"10.7326\/0003-4819-83-4-534","article-title":"Cutaneous T-cell lymphomas: the S\u00e9zary syndrome, mycosis fungoides, and related disorders","volume":"83","author":"Lutzner","year":"1975","journal-title":"Ann Intern Med"},{"key":"2026020400220145200_vzaf099-B16","doi-asserted-by":"crossref","first-page":"1931","DOI":"10.1007\/s13555-021-00625-6","article-title":"A comprehensive update of the atypical, rare and mimicking presentations of mycosis fungoides","volume":"11","author":"Lebas","year":"2021","journal-title":"Dermatol Ther (Heidelb)"},{"key":"2026020400220145200_vzaf099-B17","doi-asserted-by":"crossref","first-page":"733","DOI":"10.1111\/ijd.13589","article-title":"Occupational mycosis fungoides \u2013 a case series","volume":"56","author":"Slodownik","year":"2017","journal-title":"Int J Dermatol"},{"key":"2026020400220145200_vzaf099-B18","doi-asserted-by":"crossref","first-page":"4111","DOI":"10.21873\/anticanres.12701","article-title":"DNA from human polyoma\u00adviruses, MWPyV, HPyV6, HPyV7, HPyV9 and HPyV12 in cutaneous T-cell lymphomas","volume":"38","author":"Bergallo","year":"2018","journal-title":"Anticancer Res"},{"key":"2026020400220145200_vzaf099-B19","doi-asserted-by":"crossref","first-page":"1904","DOI":"10.1093\/cid\/ciy806","article-title":"Cutavirus DNA in malignant and nonmalignant skin of cutaneous T-cell lymphoma and organ transplant patients but not of healthy adults","volume":"68","author":"Va\u00efs\u00e4nen","year":"2019","journal-title":"Clin Infect Dis"},{"key":"2026020400220145200_vzaf099-B20","doi-asserted-by":"crossref","first-page":"1322","DOI":"10.1111\/bjd.17073","article-title":"Infectious events and\u00a0associated risk factors in mycosis fungoides\/S\u00e9zary syndrome: a retrospective cohort study","volume":"179","author":"Blaizot","year":"2018","journal-title":"Br J Dermatol"},{"key":"2026020400220145200_vzaf099-B21","doi-asserted-by":"crossref","first-page":"927","DOI":"10.1046\/j.1365-2141.1997.3213138.x","article-title":"Mycosis fungoides and S\u00e9zary syndrome are not associated with HTLV-I infection: an international study","volume":"98","author":"Bazarbachi","year":"1997","journal-title":"Br J Haematol"},{"key":"2026020400220145200_vzaf099-B22","doi-asserted-by":"crossref","first-page":"719","DOI":"10.1182\/blood.V31.6.719.719","article-title":"The ultrastructure of an abnormal cell in Se\u0301zary\u2019s syndrome","volume":"31","author":"Lutzner","year":"1968","journal-title":"Blood"},{"key":"2026020400220145200_vzaf099-B23","doi-asserted-by":"crossref","first-page":"38","DOI":"10.1001\/archderm.1971.04000190040006","article-title":"Malignant lymphoma, reticulum cell type: ultrastructural and cytological demonstration of Lutzner cells","volume":"104","author":"Petrozzi","year":"1971","journal-title":"Arch Dermatol"},{"key":"2026020400220145200_vzaf099-B24","doi-asserted-by":"crossref","first-page":"7415","DOI":"10.1073\/pnas.77.12.7415","article-title":"Detection and isolation of type C retrovirus particles from fresh and cultured lymphocytes of a patient with cutaneous T-cell lymphoma","volume":"77","author":"Poiesz","year":"1980","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020400220145200_vzaf099-B25","doi-asserted-by":"crossref","first-page":"3460","DOI":"10.1073\/pnas.82.10.3460","article-title":"T-cell receptor gene rearrangements as markers of lineage and clonality in T-cell neoplasms","volume":"82","author":"Flug","year":"1985","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020400220145200_vzaf099-B26","doi-asserted-by":"crossref","first-page":"285","DOI":"10.1007\/BF00431219","article-title":"Expression of a Hodgkin and Reed-Sternberg cell associated antigen (Ki-1) in cutaneous lymphoid infiltrates","volume":"279","author":"Ralfkiaer","year":"1987","journal-title":"Arch Dermatol Res"},{"key":"2026020400220145200_vzaf099-B27","doi-asserted-by":"crossref","first-page":"282","DOI":"10.1002\/(SICI)1096-9896(199707)182:3<282::AID-PATH864>3.0.CO;2-N","article-title":"The polymerase chain reaction in the diagnosis of early mycosis fungoides","volume":"182","author":"Liebmann","year":"1997","journal-title":"J Pathol"},{"key":"2026020400220145200_vzaf099-B28","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/j.1365-2133.2006.07526.x","article-title":"Mycosis fungoides: a dermatological masquerader","volume":"156","author":"Nashan","year":"2007","journal-title":"Br J Dermatol"},{"key":"2026020400220145200_vzaf099-B29","doi-asserted-by":"crossref","first-page":"933","DOI":"10.1097\/DAD.0000000000000207","article-title":"Mycosis fungoides: an updated review of clinicopathologic variants","volume":"36","author":"Ahn","year":"2014","journal-title":"Am J Dermatopathol"},{"key":"2026020400220145200_vzaf099-B30","volume-title":"Mycosis Fungoides","author":"Vaidya","year":"2025"},{"key":"2026020400220145200_vzaf099-B31","doi-asserted-by":"crossref","first-page":"945","DOI":"10.1016\/S0140-6736(08)60420-1","article-title":"Mycosis fungoides and S\u00e9zary syndrome","volume":"371","author":"Hwang","year":"2008","journal-title":"Lancet"},{"key":"2026020400220145200_vzaf099-B32","first-page":"594","article-title":"Pathogenesis of mycosis fungoides","volume":"9","author":"Beyer","year":"2011","journal-title":"J Dtsch Dermatol Ges"},{"key":"2026020400220145200_vzaf099-B33","doi-asserted-by":"crossref","first-page":"1703","DOI":"10.1182\/blood-2018-11-881268","article-title":"The 2018 update of the WHO-EORTC classification for primary cutaneous lymphomas","volume":"133","author":"Willemze","year":"2019","journal-title":"Blood"},{"key":"2026020400220145200_vzaf099-B34","doi-asserted-by":"crossref","first-page":"18","DOI":"10.5070\/D39ZD4C6S0","article-title":"Pagetoid reticulosis of Woringer-Kolopp","volume":"14","author":"Dusan","year":"2008","journal-title":"Dermatol Online J"},{"key":"2026020400220145200_vzaf099-B35","first-page":"e71994","article-title":"A case report of folliculotropic mycosis fungoides: diagnostic criteria and treatment strategy","volume":"16","author":"Kituashvili","year":"2024","journal-title":"Cureus"},{"key":"2026020400220145200_vzaf099-B36","doi-asserted-by":"crossref","first-page":"108","DOI":"10.3315\/jdcr.2012.1117","article-title":"Granulomatous slack skin. Histopathology diagnosis preceding clinical manifestations by 12 years","volume":"6","author":"Goldsztajn","year":"2012","journal-title":"J Dermatol Case Rep"},{"key":"2026020400220145200_vzaf099-B37","first-page":"1511","article-title":"Note on the spirochaete of yaws (Spirochaeta \u00adpertenuis)","volume":"2","author":"Castellani","year":"1907","journal-title":"BMJ"},{"key":"2026020400220145200_vzaf099-B38","doi-asserted-by":"crossref","first-page":"521","DOI":"10.3889\/oamjms.2017.122","article-title":"An overview on radiotherapy: from its history to its current applications in dermatology","volume":"5","author":"Gianfaldoni","year":"2017","journal-title":"Open Access Maced J Med Sci"},{"key":"2026020400220145200_vzaf099-B39","first-page":"623","article-title":"High energy electrons for the treatment of extensive superficial malignant lesions","volume":"69","author":"Trump","year":"1953","journal-title":"Am J Roentgenol Radium Ther Nucl Med"},{"key":"2026020400220145200_vzaf099-B40","doi-asserted-by":"crossref","first-page":"189","DOI":"10.1016\/0360-3016(87)90126-X","article-title":"The indications for total cutaneous electron beam radiation therapy of mycosis fungoides","volume":"13","author":"Le Bourgeois","year":"1987","journal-title":"Int J Radiat Oncol Biol Phys"},{"key":"2026020400220145200_vzaf099-B41","doi-asserted-by":"crossref","first-page":"2255","DOI":"10.1001\/jama.1984.03340410063036","article-title":"Nitrogen mustard therapy. Use of methyl-bis(beta-chloroethyl)amine hydrochloride and tris(beta-chloroethyl)amine hydrochloride for Hodgkin\u2019s disease, lymphosarcoma, leukemia and certain allied and miscellaneous disorders","volume":"251","author":"Goodman","year":"1984","journal-title":"JAMA"},{"key":"2026020400220145200_vzaf099-B42","doi-asserted-by":"crossref","first-page":"91","DOI":"10.3949\/ccjm.50.2.91","article-title":"Remission of lesions in mycosis fungoides following topical application of nitrogen mustard","volume":"50","author":"Haserick","year":"1983","journal-title":"Cleve Clin Q"},{"key":"2026020400220145200_vzaf099-B43","doi-asserted-by":"crossref","first-page":"288","DOI":"10.1111\/j.1396-0296.2003.01640.x","article-title":"Management with topical nitrogen mustard in mycosis fungoides","volume":"16","author":"Kim","year":"2003","journal-title":"Dermatol Ther"},{"key":"2026020400220145200_vzaf099-B44","first-page":"122","article-title":"Psoralen and ultraviolet A (PUVA) therapy in the treatment of mycosis fungoides","volume":"1","author":"Mofty","year":"1978","journal-title":"J Am Acad Dermatol"},{"key":"2026020400220145200_vzaf099-B45","first-page":"3","article-title":"Research and development of oral psoralen and longwave radiation photochemotherapy: 2000 B.C.\u20131982 A.D","volume":"66","author":"Fitzpatrick","year":"1984","journal-title":"Natl Cancer Inst Monogr"},{"key":"2026020400220145200_vzaf099-B46","doi-asserted-by":"crossref","first-page":"1207","DOI":"10.1056\/NEJM197412052912301","article-title":"Photochemotherapy of psoriasis with oral methoxsalen and longwave ultraviolet light","volume":"291","author":"Parrish","year":"1974","journal-title":"N Engl J Med"},{"key":"2026020400220145200_vzaf099-B47","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1002\/1097-0142(197608)38:2<683::AID-CNCR2820380210>3.0.CO;2-V","article-title":"Oral methoxsalen photochemotherapy of mycosis fungoides","volume":"38","author":"Gilchrest","year":"1976","journal-title":"Cancer"},{"key":"2026020400220145200_vzaf099-B48","doi-asserted-by":"crossref","first-page":"946","DOI":"10.1016\/S0190-9622(96)90119-X","article-title":"Treatment of cutaneous T-cell lymphoma with extracorporeal photopheresis monotherapy and in combination with recombinant interferon alfa: a 10-year \u00adexperience at a single institution","volume":"35","author":"Gottlieb","year":"1996","journal-title":"J Am Acad Dermatol"},{"key":"2026020400220145200_vzaf099-B49","doi-asserted-by":"crossref","first-page":"1257","DOI":"10.1136\/bmj.2.6097.1257","article-title":"Photochemotherapy in mycosis fungoides","volume":"2","author":"Hodge","year":"1977","journal-title":"Br Med J"},{"key":"2026020400220145200_vzaf099-B50","doi-asserted-by":"crossref","first-page":"379","DOI":"10.1111\/j.1365-4362.1980.tb03732.x","article-title":"Oral methoxsalen photochemotherapy of psoriasis and mycosis fungoides","volume":"19","author":"Pakkish","year":"1980","journal-title":"Int J Dermatol"},{"key":"2026020400220145200_vzaf099-B51","doi-asserted-by":"crossref","first-page":"1784","DOI":"10.1056\/NEJM198912283212603","article-title":"A randomized trial comparing combination electron-beam radiation and chemotherapy with topical therapy in the initial treatment of mycosis fungoides","volume":"321","author":"Kaye","year":"1989","journal-title":"N Engl J Med"},{"key":"2026020400220145200_vzaf099-B52","doi-asserted-by":"crossref","first-page":"258","DOI":"10.1098\/rspb.1957.0048","article-title":"Virus interference. I. The interferon","volume":"147","author":"Isaacs","year":"1957","journal-title":"Proc R Soc Lond B Biol Sci"},{"key":"2026020400220145200_vzaf099-B53","doi-asserted-by":"crossref","first-page":"1198","DOI":"10.1073\/pnas.91.4.1198","article-title":"Cytokine therapeutics: lessons from interferon \u03b1","volume":"91","author":"Gutterman","year":"1994","journal-title":"Proc Natl Acad Sci U S A"},{"key":"2026020400220145200_vzaf099-B54","doi-asserted-by":"crossref","first-page":"484","DOI":"10.7326\/0003-4819-101-4-484","article-title":"Recombinant leukocyte A interferon: an active agent in advanced cutaneous T-cell lymphomas","volume":"101","author":"Bunn","year":"1984","journal-title":"Ann Intern Med"},{"key":"2026020400220145200_vzaf099-B55","doi-asserted-by":"crossref","first-page":"584","DOI":"10.1007\/978-3-642-97234-8_74","volume-title":"Acne and Rosacea","author":"Plewig","year":"1993","edition":"2nd edn"},{"key":"2026020400220145200_vzaf099-B56","doi-asserted-by":"crossref","first-page":"1345","DOI":"10.1016\/S0140-6736(83)92136-0","article-title":"Treatment of cutaneous T-cell lymphoma (mycosis fungoides) with 13-cis-retinoic acid","volume":"321","author":"Kessler","year":"1983","journal-title":"Lancet"},{"key":"2026020400220145200_vzaf099-B57","author":"Weaver"},{"key":"2026020400220145200_vzaf099-B58","doi-asserted-by":"crossref","first-page":"146","DOI":"10.1016\/0006-291X(69)90661-5","article-title":"Enzymatic deacetylation of histone","volume":"36","author":"Inoue","year":"1969","journal-title":"Biochem Biophys Res Commun"},{"key":"2026020400220145200_vzaf099-B59","doi-asserted-by":"crossref","first-page":"3003","DOI":"10.1073\/pnas.95.6.3003","article-title":"A class of hybrid polar inducers of transformed cell differentiation inhibits histone deacetylases","volume":"95","author":"Richon","year":"1998","journal-title":"Proc Natl Acad Sci U SA"},{"key":"2026020400220145200_vzaf099-B60","doi-asserted-by":"crossref","first-page":"1247","DOI":"10.1634\/theoncologist.12-10-1247","article-title":"FDA approval summary: vorinostat for treatment of advanced primary cutaneous T-cell lymphoma","volume":"12","author":"Mann","year":"2007","journal-title":"Oncologist"},{"key":"2026020400220145200_vzaf099-B61","doi-asserted-by":"crossref","first-page":"525","DOI":"10.1038\/ja.2011.35","article-title":"Romidepsin (Istodax, NSC 630176, FR901228, FK228, depsipeptide): a natural product recently approved for cutaneous T-cell lymphoma","volume":"64","author":"VanderMolen","year":"2011","journal-title":"J Antibiot (Tokyo)"},{"key":"2026020400220145200_vzaf099-B62","doi-asserted-by":"crossref","first-page":"9","DOI":"10.4161\/19420862.2015.989042","article-title":"The therapeutic monoclonal antibody market","volume":"7","author":"Ecker","year":"2014","journal-title":"Mabs"},{"key":"2026020400220145200_vzaf099-B63","doi-asserted-by":"crossref","first-page":"1291259","DOI":"10.3389\/fimmu.2023.1291259","article-title":"Advancements in the treatment of mycosis fungoides and S\u00e9zary syndrome: monoclonal antibodies, immunotherapies, and Janus kinase inhibitors","volume":"14","author":"Quadri","year":"2023","journal-title":"Front Immunol"},{"key":"2026020400220145200_vzaf099-B64","author":"Kyowa Kirin"},{"key":"2026020400220145200_vzaf099-B65","doi-asserted-by":"crossref","first-page":"e180","DOI":"10.1634\/theoncologist.2019-0098","article-title":"FDA approval summary: brentuximab vedotin in first-line treatment of peripheral T-cell lymphoma","volume":"24","author":"Richardson","year":"2019","journal-title":"Oncologist"},{"key":"2026020400220145200_vzaf099-B66"},{"key":"2026020400220145200_vzaf099-B67"},{"key":"2026020400220145200_vzaf099-B68","doi-asserted-by":"crossref","first-page":"2365","DOI":"10.1093\/ced\/llaf341","article-title":"Mycosis fungoides: a review","volume":"50","author":"Sheern","year":"2025","journal-title":"Clin Exp Dermatol"},{"key":"2026020400220145200_vzaf099-B69","doi-asserted-by":"crossref","first-page":"1192","DOI":"10.1016\/S1470-2045(18)30379-6","article-title":"Mogamulizumab \u00adversus vorinostat in previously treated cutaneous T-cell lymphoma (MAVORIC): an international, open-label, randomised, controlled phase 3 trial","volume":"19","author":"Kim","year":"2018","journal-title":"Lancet Oncol"},{"key":"2026020400220145200_vzaf099-B70","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1177\/2040620716636541","article-title":"Mogamulizumab for the treatment of cutaneous T-cell lymphoma: recent advances and clinical potential","volume":"7","author":"Duvic","year":"2016","journal-title":"Ther Adv Hematol"},{"key":"2026020400220145200_vzaf099-B71","doi-asserted-by":"crossref","first-page":"2449","DOI":"10.1016\/j.jid.2021.01.038","article-title":"Staphylococcus aureus induces signal transducer and activator of transcription 5-dependent miR-155 expression in cutaneous T-cell lymphoma","volume":"141","author":"Willerslev-Olsen","year":"2021","journal-title":"J Invest Dermatol"}],"container-title":["Skin Health and Disease"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/1\/30\/66164071\/vzaf099.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"https:\/\/academic.oup.com\/skinhd\/article-pdf\/6\/1\/30\/66164071\/vzaf099.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,2,4]],"date-time":"2026-02-04T05:22:22Z","timestamp":1770182542000},"score":1,"resource":{"primary":{"URL":"https:\/\/academic.oup.com\/skinhd\/article\/6\/1\/30\/8407374"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,12,30]]},"references-count":71,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,12,30]]},"published-print":{"date-parts":[[2026,2,4]]}},"URL":"https:\/\/doi.org\/10.1093\/skinhd\/vzaf099","relation":{},"ISSN":["2690-442X"],"issn-type":[{"value":"2690-442X","type":"electronic"}],"subject":[],"published-other":{"date-parts":[[2026,2]]},"published":{"date-parts":[[2025,12,30]]}}}